A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy.
angiosarcoma
canine
immunotherapy
translational research
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
29
06
2023
revised:
05
08
2023
accepted:
18
08
2023
medline:
9
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
To test the antitumor effect and safety of peptide-based anticancer vaccination in dogs with hemangiosarcoma undergoing the standard of care (SOC; surgery and doxorubicin), canine hemangiosarcoma cells were infected with
Identifiants
pubmed: 37686485
pii: cancers15174209
doi: 10.3390/cancers15174209
pmc: PMC10486958
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Italian Foundation for Cancer Research grants (AIRC 5x1000(2019) "UniCanVax"
ID : No. 22757
Références
Vet Comp Oncol. 2021 Jun;19(2):311-352
pubmed: 33427378
Cell Rep. 2021 Jul 6;36(1):109312
pubmed: 34233181
Annu Rev Immunol. 2003;21:807-39
pubmed: 12615893
Cancer Res. 2014 Jan 1;74(1):104-18
pubmed: 24197130
Cancer Immunol Immunother. 2019 Nov;68(11):1839-1853
pubmed: 31222484
Nat Rev Cancer. 2008 Feb;8(2):147-56
pubmed: 18202698
J Am Anim Hosp Assoc. 1998 Sep-Oct;34(5):417-21
pubmed: 9728473
Vet Comp Oncol. 2019 Dec;17(4):537-544
pubmed: 31251441
J Vet Intern Med. 2007 Jan-Feb;21(1):113-20
pubmed: 17338158
Ann Oncol. 2013 Jan;24(1):257-63
pubmed: 22910841
Front Immunol. 2020 Jan 17;10:2935
pubmed: 32010120
Cancer Res. 2011 Jul 15;71(14):4809-20
pubmed: 21646474
J Am Vet Med Assoc. 2015 Aug 15;247(4):393-403
pubmed: 26225611
J Vet Intern Med. 1991 May-Jun;5(3):160-6
pubmed: 1920253
Adv Drug Deliv Rev. 2021 May;172:296-313
pubmed: 33705879
Vaccine. 2003 Oct 1;21(27-30):4448-58
pubmed: 14505928
Cancers (Basel). 2022 Mar 06;14(5):
pubmed: 35267655
J Transl Med. 2009 Dec 10;7:104
pubmed: 20003308
Vet Rec. 2021 Nov;189(9):e585
pubmed: 34213807
Vet Sci. 2015 Nov 06;2(4):388-405
pubmed: 29061949
Front Oncol. 2021 Nov 19;11:773420
pubmed: 34869014
Nature. 2020 Jan;577(7791):556-560
pubmed: 31942077
Mol Cancer Res. 2021 May;19(5):847-861
pubmed: 33649193
J Am Vet Med Assoc. 2005 Feb 15;226(4):575-9
pubmed: 15742699
Cancer Gene Ther. 2019 Sep;26(9-10):282-291
pubmed: 30670791
BMC Vet Res. 2020 Nov 18;16(1):447
pubmed: 33208160
Vet Comp Oncol. 2012 Mar;10(1):65-73
pubmed: 22236371
Jpn J Clin Oncol. 2019 Dec 27;49(12):1092-1099
pubmed: 31612920
J Am Vet Med Assoc. 2017 Sep 1;251(5):559-565
pubmed: 28828962
Int J Surg Case Rep. 2013;4(9):765-7
pubmed: 23856255
Vet Comp Oncol. 2023 Mar;21(1):123-130
pubmed: 36633399
Nat Med. 2022 Jun;28(6):1199-1206
pubmed: 35618839
Mol Cancer Res. 2019 Dec;17(12):2410-2421
pubmed: 31570656
Infect Immun. 2002 Nov;70(11):6147-57
pubmed: 12379692
Ann Surg. 2010 Jun;251(6):1098-106
pubmed: 20485141
J Exp Med. 2005 Dec 19;202(12):1691-701
pubmed: 16365148
J Vet Intern Med. 2004 Mar-Apr;18(2):209-13
pubmed: 15058772
Oncoimmunology. 2018 Oct 11;7(12):e1526250
pubmed: 30524908
Clin Cancer Res. 2009 Sep 15;15(18):5671-7
pubmed: 19737961
Biol Rev Camb Philos Soc. 2017 Feb;92(1):431-445
pubmed: 26565143
Vet Comp Oncol. 2014 Sep;12(3):198-204
pubmed: 22905712
Front Immunol. 2021 Aug 05;12:665784
pubmed: 34421888